Intriguingly, Tang et al. [10] similarly demonstrated aberrantly high CXCR2 expression in AML patients, linking it to adverse clinical features and extramedullary infiltration, identifying it as an independent risk factor for poor patient prognosis. The gene discussed is CXCR2; the disease is acute myeloid leukemia.